Kewaunee Scientific
(NASDAQ) KEQU
Kewaunee Scientific Financials at a Glance
Market Cap
$97.49M
Revenue (TTM)
$287.75M
Net Income (TTM)
$11.08M
EPS (TTM)
$3.72
P/E Ratio
9.14
Dividend
$0.00
Beta (Volatility)
0.46 (Low)
Dividend
$0.00
Beta (Volatility)
0.46 (Low)
Price
$34.01
Volume
302
Open
$33.99
Price
$34.01
Volume
302
Open
$33.99
Previous Close
$34.01
Daily Range
$33.99 - $34.01
52-Week Range
$30.33 - $60.89
Dividend
$0.00
Beta (Volatility)
0.46 (Low)
Price
$34.01
Volume
302
Open
$33.99
Previous Close
$34.01
Daily Range
$33.99 - $34.01
52-Week Range
$30.33 - $60.89
KEQU News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kewaunee Scientific
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
1,239
CEO
Thomas D. Hull, III, MBA
Website
www.kewaunee.comHeadquarters
Statesville, NC 28677-2927, US
KEQU Financials
Key Financial Metrics (TTM)
Gross Margin
29%
Operating Margin
7%
Net Income Margin
4%
Return on Equity
17%
Return on Capital
16%
Return on Assets
6%
Earnings Yield
10.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$97.49M
Shares Outstanding
2.87M
Volume
302
Short Interest
0.00%
Avg. Volume
6.00K
Financials (TTM)
Gross Profit
$68.86M
Operating Income
$17.76M
EBITDA
$22.76M
Operating Cash Flow
$14.78M
Capital Expenditure
$2.17M
Free Cash Flow
$12.62M
Cash & ST Invst.
$14.94M
Total Debt
$50.16M
Kewaunee Scientific Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$69.40M
+3.3%
Gross Profit
$18.55M
+0.9%
Gross Margin
26.72%
N/A
Market Cap
$97.49M
N/A
Market Cap/Employee
$96.90K
N/A
Employees
1,006
N/A
Net Income
$692.00K
-48.9%
EBITDA
$4.18M
+5.1%
Quarterly Fundamentals
Net Cash
$48.99M
-5.7%
Accounts Receivable
$54.13M
-5.7%
Inventory
$32.91M
+4.3%
Long Term Debt
$48.81M
+9.3%
Short Term Debt
$10.53M
-5.3%
Return on Assets
6.30%
N/A
Return on Invested Capital
15.73%
N/A
Free Cash Flow
$10.98M
+471.5%
Operating Cash Flow
$11.65M
+614.0%